VRTXVertex Pharmaceuticals, Inc.
VRTX
Vertex Pharmaceuticals, Inc.12,728
Mkt Cap
$114.63BVolume
369,416.0052W High
$512.7152W Low
$362.50PE Ratio
29.43VRTX Fundamentals
Price
$448.93Prev Close
$451.24Open
$447.1450D MA
$468.81Beta
0.56Avg. Volume
1.53MEPS (Annual)
$15.32P/B
6.14Rev/Employee
$1.89M$112,391.78
Promising Biotech Stocks Worth Watching - March 24th
ImmunityBio, Danaher, and Vertex Pharmaceuticals are the three Biotech stocks to watch today, according to MarketBeat's stock screener tool. For stock market investors, biotech stocks are shares of companies that research, develop, and commercialize biological therapies, diagnostics, and related te...
MarketBeat·37m ago
Anti-Aging Protein Research Takes a Step Forward with Cell Cloning
Anti-Aging Protein Research Takes a Step Forward with Cell Cloning Anti-Aging Protein Research Takes a Step Forward with Cell Cloning PR Newswire VANCOUVER, BC, March 24, 2026 Issued on behalf of Ava...
PR Newswire·2h ago
Vertex Pharmaceuticals Incorporated (VRTX) is Attracting Investor Attention: Here is What You Should Know
Recently, Zacks.com users have been paying close attention to Vertex (VRTX). This makes it worthwhile to examine what the stock has in store.
Zacks·4h ago
Wealth Enhancement Advisory Services LLC Buys 7,777 Shares of Vertex Pharmaceuticals Incorporated $VRTX
Wealth Enhancement Advisory Services LLC boosted its position in shares of Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX - Free Report) by 10.6% in the 4th quarter, according to its most recent disclosure with the Securities & Exchange Commission. The firm owned 81,246 shares of the pharmace...
MarketBeat·5h ago
Assenagon Asset Management S.A. Has $377.58 Million Stock Holdings in Vertex Pharmaceuticals Incorporated $VRTX
Assenagon Asset Management S.A. lifted its holdings in shares of Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX - Free Report) by 9.1% during the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 83...
MarketBeat·10h ago
Promising Biotech Stocks To Consider - March 23rd
Apogee Therapeutics, Danaher, bioAffinity Technologies, ImmunityBio, argenex, Moderna, and Vertex Pharmaceuticals are the seven Biotech stocks to watch today, according to MarketBeat's stock screener tool. Biotech stocks are shares of publicly traded companies whose primary business is developing b...
MarketBeat·23h ago
Westview Management dba Westview Investment Advisors Invests $2.85 Million in Vertex Pharmaceuticals Incorporated $VRTX
Westview Management dba Westview Investment Advisors acquired a new stake in Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX - Free Report) in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm acquired 6,284 sha...
MarketBeat·1d ago
Gradient Investments LLC Has $19.76 Million Stock Holdings in Vertex Pharmaceuticals Incorporated $VRTX
Gradient Investments LLC boosted its stake in shares of Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX - Free Report) by 6.4% in the fourth quarter, according to the company in its most recent Form...
MarketBeat·1d ago
Nordea Investment Management AB Has $202.61 Million Position in Vertex Pharmaceuticals Incorporated $VRTX
Nordea Investment Management AB boosted its holdings in shares of Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX - Free Report) by 23.8% in the fourth quarter, according to its most recent filing...
MarketBeat·1d ago
Biotech Stocks Worth Watching - March 22nd
Danaher, Vertex Pharmaceuticals, and Moderna are the three Biotech stocks to watch today, according to MarketBeat's stock screener tool. Biotech stocks are shares of companies whose primary business is biotechnology developing drugs, biologics, diagnostics, gene therapies, or other lifescience t...
MarketBeat·2d ago
<
1
2
...
>